• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Telomir Pharmaceuticals, Inc. - Common Stock (NQ:TELO)

1.500 -0.160 (-9.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Telomir Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Stock Market Today: Nvidia Drags Down Nasdaq Futures—Dollar General, Dell, Best Buy In Focus
August 28, 2025
U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largely mixed. 
Via Benzinga
Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
August 28, 2025
 
Via Benzinga
Why Telomir Pharmaceuticals Stock Ran Up 35% On Wednesday Night
August 28, 2025
Telomir Pharmaceuticals' shares jumped 35% after promising data showed its lead drug Telomir-1 may offer a safer, dual-action treatment for cancer and aging-related diseases. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 27, 2025
 
Via Benzinga
Wednesday's after hours session: top gainers and losers
August 27, 2025
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction
August 07, 2025
Via ACCESS Newswire
Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathways in
July 24, 2025
Via ACCESS Newswire
Get insights into the top gainers and losers of Monday's pre-market session.
July 21, 2025
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 21, 2025
 
Via Benzinga
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
July 21, 2025
 
Via Benzinga
Top stock movements in today's session.
July 18, 2025
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Most active stocks in Friday's session
July 18, 2025
Discover the most active stocks in Friday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
July 18, 2025
 
Via Benzinga
Dow Falls Over 200 Points; 3M Earnings Top Views
July 18, 2025
 
Via Benzinga
Topics Stocks
On Friday, there are stocks with unusual volume. Let's take a look.
July 18, 2025
On Friday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
Friday's session: top gainers and losers
July 18, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Gapping stocks in Friday's session
July 18, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
US Stocks Mixed; American Express Posts Upbeat Q2 Results
July 18, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 18, 2025
 
Via Benzinga
Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin
July 18, 2025
Via ACCESS Newswire
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
July 18, 2025
 
Via Benzinga
US Stocks Likely To Open Higher After Scaling Record Close: American Express, 3M, Charles Schwab Earnings In Focus
July 18, 2025
U.S. stock futures were positive on Friday after ending higher on Thursday. Futures of major benchmark indices were higher. 
Via Benzinga
Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests
July 18, 2025
Following the announcement of promising data regarding Telomir-1, Telomir Pharmaceuticals Inc stock surged 138.84% during after-hours trading on Thursday, 
Via Benzinga
Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells; Retail Eyes Bigger Gains
July 17, 2025
The early lab study used cells from a child with progeria and showed improvements in cell survival, reduced oxidative stress, and restored mitochondrial function, which are key signs of aging. 
Via Stocktwits
12 Health Care Stocks Moving In Thursday's After-Market Session
July 17, 2025
 
Via Benzinga
Which stocks are moving after the closing bell on Thursday?
July 17, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
June 30, 2025
 
Via Benzinga
BioMedNewsBreaks — Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Success for Telomir-1 in Progeria Cell Lines
June 18, 2025
Via Investor Brand Network
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
June 18, 2025
Via ACCESS Newswire
EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria
June 18, 2025
Telomir-1 improved cell survival, reduced oxidative stress, and restored mitochondrial balance in preclinical progeria study. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap